Timeliness of pre-operative aspirin before coronary artery bypass grafting (CABG): A clinical audit
Bioinformation · 31.10.2026 · 22 (10) · 7142-7145
DOI: 10.6026/973206300227142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Surendra Singh Yadav.
Abstract (Originalsprache)
Omission or poorly timed aspirin before coronary artery bypass grafting (CABG) may compromise graft patency and post-operative outcomes. Therefore, it is of interest to evaluate the compliance with evidence-based recommendations for timely pre-operative aspirin administration at a tertiary care centre in Central India. A retrospective standards-based audit of 60 consecutive adult patients undergoing isolated CABG was conducted against predefined institutional standards. Aspirin was administered to 91.7% of eligible patients, and 86.7% received the last dose within 24 hours of surgery, exceeding the audit benchmark. Thus, medication omission, inadequate documentation and surgeon-directed discontinuation were the main causes of non-compliance, indicating a need for better documentation and medication reconciliation.
Zitieren
APA
Yadav, S. S. (2026). Timeliness of pre-operative aspirin before coronary artery bypass grafting (CABG): A clinical audit. Bioinformation, 22(10), 7142-7145. https://doi.org/10.6026/973206300227142
Vancouver
Yadav SS. Timeliness of pre-operative aspirin before coronary artery bypass grafting (CABG): A clinical audit. Bioinformation. 2026;22(10):7142-7145. doi:10.6026/973206300227142
BibTeX
@article{Yadav2026,
author = {Yadav, Surendra Singh},
title = {Timeliness of pre-operative aspirin before coronary artery bypass grafting (CABG): A clinical audit},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {7142--7145},
doi = {10.6026/973206300227142}
}
EUVIMED